The 11-hospital safety-net system has about 18 days of cash on hand, according to the report. Its cash on hand has been dwindling as the system has been losing roughly $20 million a week in revenue since about mid-March, when elective procedures were suspended to help address the COVID-19 pandemic.
New York City Health + Hospitals said the expected cost of treating COVID-19 patients, including costs for equipment, staffing and supplies, will reach $1.1 billion.
“Where it’s going to get difficult for us is now we gotta pay those bills,” John Ulberg, CFO of New York City Health + Hospitals, told the WSJ.
The hospital system said it has received $824 million in federal relief funding so far, and it hopes to secure additional funding that HHS is giving to safety-net hospitals that have already received funds.
New York City Health + Hospitals told the WSJ it will hold off on making cuts or layoffs until it understands how much federal funding it will receive.
More articles on healthcare finance:
10 latest hospital credit rating downgrades
8 nonprofit health systems got $1.7B bailout, furloughed more than 30,000 workers
State-by-state breakdown of 130 rural hospital closures
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
